4.7 Article

TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling

期刊

CELL DEATH & DISEASE
卷 12, 期 11, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41419-021-04336-w

关键词

-

资金

  1. Construction Project of Fujian Medical Center of Hematology [Min201704]
  2. National and Fujian Provincial Key Clinical Specialty Discipline Construction Program P.R.C.
  3. Joint Funds for the Innovation of Science and Technology, Fujian province [2017Y9054]
  4. Fujian Natural Science Foundation [2019J01156]

向作者/读者索取更多资源

In this study, it was found that elevated expression of TCP1 in acute myeloid leukemia patients was associated with low complete response rate and poor overall survival. Further investigations revealed that TCP1 contributes to drug resistance by inhibiting autophagy and activating the AKT/mTOR signaling pathway. Targeting the TCP1/AKT/mTOR signaling pathway provides a new strategy for overcoming drug resistance in AML.
T-complex protein 1 (TCP1) is one of the subunits of chaperonin-containing T complex (CCT), which is involved in protein folding, cell proliferation, apoptosis, cell cycle regulation, and drug resistance. Investigations have demonstrated that TCP1 is a factor being responsible for drug resistance in breast and ovarian cancer. However, the TCP1 role in acute myeloid leukemia (AML) remains elusive. In the present study, we discovered that the TCP1 expression was elevated in AML patients and high TCP1 expression was associated with low complete response rate along with poor overall survival. TCP1 showed higher expression in the adriamycin-resistant leukemia cell line HL60/A and K562/A, comparing to their respective parent cells HL60 and K562 cells. TCP1 inhibition suppressed drug resistance in HL60/A and K562/A cells, whereas TCP1 overexpression in HL60 cells incremented drug resistance, both in vitro and in vivo. Mechanistic investigations revealed that TCP1 inhibited autophagy and adriamycin-induced cell apoptosis, and TCP1-mediated autophagy inhibition conferred resistance to adriamycin-induced cell apoptosis. Furthermore, TCP1 interacted with AKT and mTOR to activate AKT/mTOR signaling, which negatively regulates apoptosis and autophagy. Pharmacological inhibition of AKT/mTOR signal particularly activated autophagy and resensitized TCP1-overexpressing HL60 cells to adriamycin. These findings identify a novel role of TCP1 regarding drug resistance in AML, which advise a new strategy for overcoming drug resistance in AML through targeting TCP1/AKT/mTOR signaling pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据